instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Azoospermia'. | Stimulant-Induced Pituitary Failure and Reversible Azoospermia.
Attention-deficit hyperactivity disorder (ADHD) is a commonly diagnosed disorder that is managed with stimulant medications, which function by increasing the levels of dopamine in the brain. Excess dopamine has been known to affect several body systems, in... | AMPHETAMINE ASPARTATE\AMPHETAMINE SULFATE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE SULFATE, BUPRENORPHINE, RISPERIDONE | DrugsGivenReaction | CC BY | 33959450 | 19,286,306 | 2021-04-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypopituitarism'. | Stimulant-Induced Pituitary Failure and Reversible Azoospermia.
Attention-deficit hyperactivity disorder (ADHD) is a commonly diagnosed disorder that is managed with stimulant medications, which function by increasing the levels of dopamine in the brain. Excess dopamine has been known to affect several body systems, in... | AMPHETAMINE ASPARTATE\AMPHETAMINE SULFATE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE SULFATE, BUPRENORPHINE, RISPERIDONE | DrugsGivenReaction | CC BY | 33959450 | 19,286,306 | 2021-04-03 |
What was the outcome of reaction 'Azoospermia'? | Stimulant-Induced Pituitary Failure and Reversible Azoospermia.
Attention-deficit hyperactivity disorder (ADHD) is a commonly diagnosed disorder that is managed with stimulant medications, which function by increasing the levels of dopamine in the brain. Excess dopamine has been known to affect several body systems, in... | Recovered | ReactionOutcome | CC BY | 33959450 | 19,286,306 | 2021-04-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | LENVATINIB | DrugsGivenReaction | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | LENVATINIB | DrugsGivenReaction | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiomyopathy'. | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | LENVATINIB | DrugsGivenReaction | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | LENVATINIB | DrugsGivenReaction | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephrotic syndrome'. | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | LENVATINIB | DrugsGivenReaction | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | LENVATINIB | DrugsGivenReaction | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
What is the weight of the patient? | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | 49 kg. | Weight | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
What was the administration route of drug 'LENVATINIB'? | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | Oral | DrugAdministrationRoute | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
What was the outcome of reaction 'Acute kidney injury'? | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | Recovering | ReactionOutcome | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
What was the outcome of reaction 'Anaemia'? | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | Recovering | ReactionOutcome | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
What was the outcome of reaction 'Nephrotic syndrome'? | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | Recovering | ReactionOutcome | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
What was the outcome of reaction 'Thrombocytopenia'? | Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.
BACKGROUND
The management of metastatic progressive radioiodine-resistant differentiated thyroid cancer remains challenging for clinicians. The availability of tyrosine kinase inhibitors (TKIs), sorafenib and lenvatinib, within ... | Recovering | ReactionOutcome | CC BY-NC | 33959480 | 19,229,794 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin exfoliation'. | Factors Predicting the Outcome of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 5-Year Retrospective Study.
Clinicodemographic and laboratory parameters predicting the outcome of Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) may vary among populations owing to genotypic and environmental ... | LAMOTRIGINE | DrugsGivenReaction | CC BY-NC-SA | 33959522 | 19,289,392 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stevens-Johnson syndrome'. | Factors Predicting the Outcome of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 5-Year Retrospective Study.
Clinicodemographic and laboratory parameters predicting the outcome of Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) may vary among populations owing to genotypic and environmental ... | LAMOTRIGINE | DrugsGivenReaction | CC BY-NC-SA | 33959522 | 19,289,396 | 2021 |
What was the outcome of reaction 'Toxic epidermal necrolysis'? | Factors Predicting the Outcome of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 5-Year Retrospective Study.
Clinicodemographic and laboratory parameters predicting the outcome of Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) may vary among populations owing to genotypic and environmental ... | Fatal | ReactionOutcome | CC BY-NC-SA | 33959522 | 19,289,392 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myocardial infarction'. | A case report: adenosine triggered myocardial infarction during myocardial perfusion stress test imaging in a diabetic patient.
Myocardial perfusion imaging (MPI) using single-photon emission computed tomography (SPECT) can in general be used safely in daily clinical practice. However, under the right circumstances, it... | ADENOSINE | DrugsGivenReaction | CC BY-NC | 33959698 | 20,142,065 | 2021-04 |
What was the outcome of reaction 'Acute myocardial infarction'? | A case report: adenosine triggered myocardial infarction during myocardial perfusion stress test imaging in a diabetic patient.
Myocardial perfusion imaging (MPI) using single-photon emission computed tomography (SPECT) can in general be used safely in daily clinical practice. However, under the right circumstances, it... | Recovered | ReactionOutcome | CC BY-NC | 33959698 | 20,142,065 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature.
Isocitrate dehydrogenase (IDH) mutations are rare in pediatric and adolescent gliomas. We recently identified three adolescent/young adult (AYA) patients with IDH-mutant low grade gliomas of the brai... | CARBOPLATIN, TEMOZOLOMIDE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-ND | 33960568 | 19,691,890 | 2021-07 |
What was the dosage of drug 'CARBOPLATIN'? | IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature.
Isocitrate dehydrogenase (IDH) mutations are rare in pediatric and adolescent gliomas. We recently identified three adolescent/young adult (AYA) patients with IDH-mutant low grade gliomas of the brai... | UNK, CYCLIC (FIVE CYCLES) | DrugDosageText | CC BY-NC-ND | 33960568 | 19,691,890 | 2021-07 |
What was the dosage of drug 'TEMOZOLOMIDE'? | IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature.
Isocitrate dehydrogenase (IDH) mutations are rare in pediatric and adolescent gliomas. We recently identified three adolescent/young adult (AYA) patients with IDH-mutant low grade gliomas of the brai... | UNK, CYCLIC (FIVE CYCLES) | DrugDosageText | CC BY-NC-ND | 33960568 | 19,691,890 | 2021-07 |
What was the dosage of drug 'VINCRISTINE SULFATE'? | IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature.
Isocitrate dehydrogenase (IDH) mutations are rare in pediatric and adolescent gliomas. We recently identified three adolescent/young adult (AYA) patients with IDH-mutant low grade gliomas of the brai... | UNK, CYCLIC (5 CYCLES) | DrugDosageText | CC BY-NC-ND | 33960568 | 19,691,890 | 2021-07 |
What was the outcome of reaction 'Neoplasm progression'? | IDH-mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature.
Isocitrate dehydrogenase (IDH) mutations are rare in pediatric and adolescent gliomas. We recently identified three adolescent/young adult (AYA) patients with IDH-mutant low grade gliomas of the brai... | Fatal | ReactionOutcome | CC BY-NC-ND | 33960568 | 19,691,890 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Candida infection'. | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | AMIKACIN, BENDAMUSTINE, CARMUSTINE, CEFTAZIDIME, CEFTRIAXONE, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FLUCONAZOLE, GEMCITABINE, MELPHALAN, MEROPENEM, METHOTREXATE, OXALIPLATIN, POLATUZUMAB VEDOTIN, PREDNISOLONE, RITUXIMAB, VENETOCLAX, VINCRISTINE | DrugsGivenReaction | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Candida pneumonia'. | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | AMIKACIN, BENDAMUSTINE, CARMUSTINE, CEFTAZIDIME, CEFTRIAXONE, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FLUCONAZOLE, GEMCITABINE, MELPHALAN, MEROPENEM, METHOTREXATE, OXALIPLATIN, POLATUZUMAB VEDOTIN, PREDNISOLONE, RITUXIMAB, VENETOCLAX, VINCRISTINE | DrugsGivenReaction | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diffuse large B-cell lymphoma recurrent'. | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | AMIKACIN, BENDAMUSTINE, CARMUSTINE, CEFTAZIDIME, CEFTRIAXONE, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FLUCONAZOLE, GEMCITABINE, MELPHALAN, MEROPENEM, METHOTREXATE, OXALIPLATIN, POLATUZUMAB VEDOTIN, PREDNISOLONE, RITUXIMAB, VENETOCLAX, VINCRISTINE | DrugsGivenReaction | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | AMIKACIN, BENDAMUSTINE, CARMUSTINE, CEFTAZIDIME, CEFTRIAXONE, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FLUCONAZOLE, GEMCITABINE, MELPHALAN, MEROPENEM, METHOTREXATE, OXALIPLATIN, POLATUZUMAB VEDOTIN, PREDNISOLONE, RITUXIMAB, VENETOCLAX, VINCRISTINE | DrugsGivenReaction | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | AMIKACIN, BENDAMUSTINE, CARMUSTINE, CEFTAZIDIME, CEFTRIAXONE, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FLUCONAZOLE, GEMCITABINE, MELPHALAN, MEROPENEM, METHOTREXATE, OXALIPLATIN, POLATUZUMAB VEDOTIN, PREDNISOLONE, RITUXIMAB, VENETOCLAX, VINCRISTINE | DrugsGivenReaction | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'General physical health deterioration'. | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | AMIKACIN, BENDAMUSTINE, CARMUSTINE, CEFTAZIDIME, CEFTRIAXONE, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FLUCONAZOLE, GEMCITABINE, MELPHALAN, MEROPENEM, METHOTREXATE, OXALIPLATIN, POLATUZUMAB VEDOTIN, PREDNISOLONE, RITUXIMAB, VENETOCLAX, VINCRISTINE | DrugsGivenReaction | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | AMIKACIN, BENDAMUSTINE, CARMUSTINE, CEFTAZIDIME, CEFTRIAXONE, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FLUCONAZOLE, GEMCITABINE, MELPHALAN, MEROPENEM, METHOTREXATE, OXALIPLATIN, POLATUZUMAB VEDOTIN, PREDNISOLONE, RITUXIMAB, VENETOCLAX, VINCRISTINE | DrugsGivenReaction | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | AMIKACIN, BENDAMUSTINE, CARMUSTINE, CEFTAZIDIME, CEFTRIAXONE, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FLUCONAZOLE, GEMCITABINE, MELPHALAN, MEROPENEM, METHOTREXATE, OXALIPLATIN, POLATUZUMAB VEDOTIN, PREDNISOLONE, RITUXIMAB, VENETOCLAX, VINCRISTINE | DrugsGivenReaction | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | AMIKACIN, BENDAMUSTINE, CARMUSTINE, CEFTAZIDIME, CEFTRIAXONE, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FLUCONAZOLE, GEMCITABINE, MELPHALAN, MEROPENEM, METHOTREXATE, OXALIPLATIN, POLATUZUMAB VEDOTIN, PREDNISOLONE, RITUXIMAB, VENETOCLAX, VINCRISTINE | DrugsGivenReaction | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | AMIKACIN, BENDAMUSTINE, CARMUSTINE, CEFTAZIDIME, CEFTRIAXONE, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FLUCONAZOLE, GEMCITABINE, MELPHALAN, MEROPENEM, METHOTREXATE, OXALIPLATIN, POLATUZUMAB VEDOTIN, PREDNISOLONE, RITUXIMAB, VENETOCLAX, VINCRISTINE | DrugsGivenReaction | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | AMIKACIN, BENDAMUSTINE, CARMUSTINE, CEFTAZIDIME, CEFTRIAXONE, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, FLUCONAZOLE, GEMCITABINE, MELPHALAN, MEROPENEM, METHOTREXATE, OXALIPLATIN, POLATUZUMAB VEDOTIN, PREDNISOLONE, RITUXIMAB, VENETOCLAX, VINCRISTINE | DrugsGivenReaction | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
What was the administration route of drug 'RITUXIMAB'? | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
What was the dosage of drug 'BENDAMUSTINE'? | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | 70 MG/M2, CYCLIC (ON DAYS 1 AND 2 OF EACH CYCLE, FOR 6 CYCLES EVERY 28 DAYS | DrugDosageText | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
What was the outcome of reaction 'Candida infection'? | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | Recovering | ReactionOutcome | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
What was the outcome of reaction 'Febrile neutropenia'? | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | Recovering | ReactionOutcome | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
What was the outcome of reaction 'General physical health deterioration'? | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | Recovering | ReactionOutcome | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
What was the outcome of reaction 'Respiratory failure'? | Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient-case report.
BACKGROUND
Cardiac tumors are very uncommon compared to other cardiac diseases. Their clinical symptoms can vary from absent to non-specific. The most common symptoms are arrhy... | Recovering | ReactionOutcome | CC BY | 33962562 | 19,748,283 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Patient with respiratory distress, facial oedema and refractory hypokalaemia.
Small cell lung carcinoma, when associated with co-occurrence of complications such as paraneoplastic syndrome and superior vena cava syndrome, poses a greater management challenge to the clinical team. We report a 56-year-old man who was eve... | POTASSIUM CHLORIDE | DrugsGivenReaction | CC BY-NC | 33962921 | 19,513,969 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Patient with respiratory distress, facial oedema and refractory hypokalaemia.
Small cell lung carcinoma, when associated with co-occurrence of complications such as paraneoplastic syndrome and superior vena cava syndrome, poses a greater management challenge to the clinical team. We report a 56-year-old man who was eve... | CISPLATIN, ETOPOSIDE, KETOCONAZOLE, POTASSIUM CHLORIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC | 33962921 | 19,439,221 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Patient with respiratory distress, facial oedema and refractory hypokalaemia.
Small cell lung carcinoma, when associated with co-occurrence of complications such as paraneoplastic syndrome and superior vena cava syndrome, poses a greater management challenge to the clinical team. We report a 56-year-old man who was eve... | CISPLATIN, ETOPOSIDE, KETOCONAZOLE, POTASSIUM CHLORIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC | 33962921 | 19,439,221 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory arrest'. | Patient with respiratory distress, facial oedema and refractory hypokalaemia.
Small cell lung carcinoma, when associated with co-occurrence of complications such as paraneoplastic syndrome and superior vena cava syndrome, poses a greater management challenge to the clinical team. We report a 56-year-old man who was eve... | CISPLATIN, ETOPOSIDE, KETOCONAZOLE, POTASSIUM CHLORIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC | 33962921 | 19,439,221 | 2021-05-07 |
What is the weight of the patient? | Patient with respiratory distress, facial oedema and refractory hypokalaemia.
Small cell lung carcinoma, when associated with co-occurrence of complications such as paraneoplastic syndrome and superior vena cava syndrome, poses a greater management challenge to the clinical team. We report a 56-year-old man who was eve... | 47 kg. | Weight | CC BY-NC | 33962921 | 19,439,221 | 2021-05-07 |
What was the administration route of drug 'CISPLATIN'? | Patient with respiratory distress, facial oedema and refractory hypokalaemia.
Small cell lung carcinoma, when associated with co-occurrence of complications such as paraneoplastic syndrome and superior vena cava syndrome, poses a greater management challenge to the clinical team. We report a 56-year-old man who was eve... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33962921 | 19,439,221 | 2021-05-07 |
What was the administration route of drug 'ETOPOSIDE'? | Patient with respiratory distress, facial oedema and refractory hypokalaemia.
Small cell lung carcinoma, when associated with co-occurrence of complications such as paraneoplastic syndrome and superior vena cava syndrome, poses a greater management challenge to the clinical team. We report a 56-year-old man who was eve... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33962921 | 19,439,221 | 2021-05-07 |
What was the administration route of drug 'POTASSIUM CHLORIDE'? | Patient with respiratory distress, facial oedema and refractory hypokalaemia.
Small cell lung carcinoma, when associated with co-occurrence of complications such as paraneoplastic syndrome and superior vena cava syndrome, poses a greater management challenge to the clinical team. We report a 56-year-old man who was eve... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33962921 | 19,513,969 | 2021-05-07 |
What was the outcome of reaction 'Neutropenia'? | Patient with respiratory distress, facial oedema and refractory hypokalaemia.
Small cell lung carcinoma, when associated with co-occurrence of complications such as paraneoplastic syndrome and superior vena cava syndrome, poses a greater management challenge to the clinical team. We report a 56-year-old man who was eve... | Fatal | ReactionOutcome | CC BY-NC | 33962921 | 19,439,221 | 2021-05-07 |
What was the outcome of reaction 'Pneumonia'? | Patient with respiratory distress, facial oedema and refractory hypokalaemia.
Small cell lung carcinoma, when associated with co-occurrence of complications such as paraneoplastic syndrome and superior vena cava syndrome, poses a greater management challenge to the clinical team. We report a 56-year-old man who was eve... | Fatal | ReactionOutcome | CC BY-NC | 33962921 | 19,439,221 | 2021-05-07 |
What was the outcome of reaction 'Respiratory arrest'? | Patient with respiratory distress, facial oedema and refractory hypokalaemia.
Small cell lung carcinoma, when associated with co-occurrence of complications such as paraneoplastic syndrome and superior vena cava syndrome, poses a greater management challenge to the clinical team. We report a 56-year-old man who was eve... | Fatal | ReactionOutcome | CC BY-NC | 33962921 | 19,439,221 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucormycosis'. | Sino-orbital mucormycosis in a COVID-19 patient: A case report.
BACKGROUND
We report a case of post COVID-19 Sino-orbital Mucormycosis infection caused by Rhizopus oryzae and its management.
METHODS
The patient was diagnosed with COVID-19 and treated according to the persisting protocols. Following recovery, on the 1... | DEXAMETHASONE, METHYLPREDNISOLONE, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 33964720 | 19,381,542 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Sino-orbital mucormycosis in a COVID-19 patient: A case report.
BACKGROUND
We report a case of post COVID-19 Sino-orbital Mucormycosis infection caused by Rhizopus oryzae and its management.
METHODS
The patient was diagnosed with COVID-19 and treated according to the persisting protocols. Following recovery, on the 1... | DEXAMETHASONE, METHYLPREDNISOLONE, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 33964720 | 19,381,542 | 2021-05 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Sino-orbital mucormycosis in a COVID-19 patient: A case report.
BACKGROUND
We report a case of post COVID-19 Sino-orbital Mucormycosis infection caused by Rhizopus oryzae and its management.
METHODS
The patient was diagnosed with COVID-19 and treated according to the persisting protocols. Following recovery, on the 1... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33964720 | 19,381,542 | 2021-05 |
What was the administration route of drug 'REMDESIVIR'? | Sino-orbital mucormycosis in a COVID-19 patient: A case report.
BACKGROUND
We report a case of post COVID-19 Sino-orbital Mucormycosis infection caused by Rhizopus oryzae and its management.
METHODS
The patient was diagnosed with COVID-19 and treated according to the persisting protocols. Following recovery, on the 1... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33964720 | 19,381,542 | 2021-05 |
What was the dosage of drug 'DEXAMETHASONE'? | Sino-orbital mucormycosis in a COVID-19 patient: A case report.
BACKGROUND
We report a case of post COVID-19 Sino-orbital Mucormycosis infection caused by Rhizopus oryzae and its management.
METHODS
The patient was diagnosed with COVID-19 and treated according to the persisting protocols. Following recovery, on the 1... | 4 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33964720 | 19,381,542 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.
BACKGROUND
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell d... | DUPILUMAB | DrugsGivenReaction | CC BY | 33964871 | 18,685,993 | 2021-05-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis ulcerative'. | Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.
BACKGROUND
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell d... | DUPILUMAB | DrugsGivenReaction | CC BY | 33964871 | 18,685,993 | 2021-05-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.
BACKGROUND
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell d... | DUPILUMAB | DrugsGivenReaction | CC BY | 33964871 | 18,685,993 | 2021-05-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Frequent bowel movements'. | Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.
BACKGROUND
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell d... | DUPILUMAB | DrugsGivenReaction | CC BY | 33964871 | 18,685,993 | 2021-05-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematochezia'. | Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.
BACKGROUND
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell d... | DUPILUMAB | DrugsGivenReaction | CC BY | 33964871 | 18,685,993 | 2021-05-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rectal tenesmus'. | Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.
BACKGROUND
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell d... | DUPILUMAB | DrugsGivenReaction | CC BY | 33964871 | 18,685,993 | 2021-05-08 |
What is the weight of the patient? | Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.
BACKGROUND
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell d... | 70 kg. | Weight | CC BY | 33964871 | 18,685,993 | 2021-05-08 |
What was the administration route of drug 'DUPILUMAB'? | Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.
BACKGROUND
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell d... | Subcutaneous | DrugAdministrationRoute | CC BY | 33964871 | 18,685,993 | 2021-05-08 |
What was the outcome of reaction 'Diarrhoea'? | Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.
BACKGROUND
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell d... | Recovering | ReactionOutcome | CC BY | 33964871 | 18,685,993 | 2021-05-08 |
What was the outcome of reaction 'Frequent bowel movements'? | Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.
BACKGROUND
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell d... | Recovering | ReactionOutcome | CC BY | 33964871 | 18,685,993 | 2021-05-08 |
What was the outcome of reaction 'Haematochezia'? | Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report.
BACKGROUND
Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell d... | Recovering | ReactionOutcome | CC BY | 33964871 | 18,685,993 | 2021-05-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood pressure inadequately controlled'. | Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report study.
Blood Pressure (BP) control is largely unsatisfied in End Stage Kidney Disease (ESKD) principally due to sodium retention. Peritoneal Dialysis (PD) is the most common type of home dialysis, usin... | AMLODIPINE BESYLATE, DOXAZOSIN MESYLATE, FUROSEMIDE, TELMISARTAN | DrugsGivenReaction | CC BY | 33964894 | 20,067,432 | 2021-05-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report study.
Blood Pressure (BP) control is largely unsatisfied in End Stage Kidney Disease (ESKD) principally due to sodium retention. Peritoneal Dialysis (PD) is the most common type of home dialysis, usin... | AMLODIPINE BESYLATE, DOXAZOSIN MESYLATE, FUROSEMIDE, TELMISARTAN | DrugsGivenReaction | CC BY | 33964894 | 20,082,651 | 2021-05-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report study.
Blood Pressure (BP) control is largely unsatisfied in End Stage Kidney Disease (ESKD) principally due to sodium retention. Peritoneal Dialysis (PD) is the most common type of home dialysis, usin... | AMLODIPINE BESYLATE, DOXAZOSIN MESYLATE, FUROSEMIDE, TELMISARTAN | DrugsGivenReaction | CC BY | 33964894 | 20,067,432 | 2021-05-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | AMIODARONE HYDROCHLORIDE, AMLODIPINE BESYLATE, ASPIRIN, BACLOFEN, BISOPROLOL, DIMETHICONE, FONDAPARINUX, FUROSEMIDE, GABAPENTIN, IRON, PANTOPRAZOLE, POLYETHYLENE GLYCOLS, POTASSIUM, PROBIOTICS NOS, SILODOSIN, SODIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC\SODIUM PHOSPHATE, MONOBASIC, VANCOMYCIN, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Potentiating drug interaction'. | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | AMIODARONE HYDROCHLORIDE, AMLODIPINE BESYLATE, ASPIRIN, BACLOFEN, BISOPROLOL FUMARATE, DIMETHICONE, FONDAPARINUX SODIUM, FUROSEMIDE, GABAPENTIN, IRON, PANTOPRAZOLE SODIUM, POLYETHYLENE GLYCOLS, POTASSIUM ACETATE, PROBIOTICS NOS, SILODOSIN, SODIUM CHLORIDE, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33964989 | 19,303,292 | 2021-05-09 |
What was the administration route of drug 'AMIODARONE HYDROCHLORIDE'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,303,292 | 2021-05-09 |
What was the administration route of drug 'AMLODIPINE BESYLATE'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the administration route of drug 'ASPIRIN'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the administration route of drug 'BACLOFEN'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,326,314 | 2021-05-09 |
What was the administration route of drug 'BISOPROLOL'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the administration route of drug 'DIMETHICONE'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,326,314 | 2021-05-09 |
What was the administration route of drug 'FONDAPARINUX'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Subcutaneous | DrugAdministrationRoute | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the administration route of drug 'FUROSEMIDE'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,326,314 | 2021-05-09 |
What was the administration route of drug 'GABAPENTIN ENACARBIL'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,326,314 | 2021-05-09 |
What was the administration route of drug 'GABAPENTIN'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the administration route of drug 'IRON'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33964989 | 19,326,314 | 2021-05-09 |
What was the administration route of drug 'PANTOPRAZOLE SODIUM'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,303,292 | 2021-05-09 |
What was the administration route of drug 'PANTOPRAZOLE'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,326,314 | 2021-05-09 |
What was the administration route of drug 'POLYETHYLENE GLYCOLS'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the administration route of drug 'POTASSIUM ACETATE'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,303,292 | 2021-05-09 |
What was the administration route of drug 'POTASSIUM CHLORIDE'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,326,314 | 2021-05-09 |
What was the administration route of drug 'POTASSIUM'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the administration route of drug 'PROBIOTICS NOS'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the administration route of drug 'SILODOSIN'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33964989 | 19,326,314 | 2021-05-09 |
What was the administration route of drug 'VANCOMYCIN'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the administration route of drug 'ZOLPIDEM TARTRATE'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Oral | DrugAdministrationRoute | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the dosage of drug 'FONDAPARINUX'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | 2.5 MG/0.5 ML PER DAY | DrugDosageText | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the dosage of drug 'POTASSIUM CHLORIDE'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | 600 MG, UNK | DrugDosageText | CC BY | 33964989 | 19,326,314 | 2021-05-09 |
What was the dosage of drug 'POTASSIUM'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | 600 MG, 2X/DAY | DrugDosageText | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the outcome of reaction 'Coma'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Recovered | ReactionOutcome | CC BY | 33964989 | 19,326,314 | 2021-05-09 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.